Document is current
Any future updates will be listed below
-
Authors
Rudolph, Abby E.
Nance, Robin M.
Bobashev, Georgiy
Brook, Daniel
Akhtar, Wajiha
Cook, Ryan
Cooper, Hannah L.
Friedmann, Peter D.
Frost, Simon D. W.
Go, Vivian F.
Jenkins, Wiley D.
Korthuis, Philip T.
Miller, William C.
Pho, Mai T.
Ruderman, Stephanie A.
Seal, David W.
Stopka, Thomas J.
Westergaard, Ryan P.
Young, April M.
Zule, William A.
Tsui, Judith I.
Crane, Heidi M.
Whitney, Bridget M.
Delaney, Joseph A. C.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (U24DA048538, U24DA048538, UG3DA044822, UG3DA044826, UG3DA044831, UG3DA044798, UG3DA044830, U24DA048538, UG3DA044822, UG3DA044829, UG3DA044831, UG3DA044822, UG3DA044829, U24DA048538, UG3DA044826, UG3DA044830, UG3DA044826, U24DA048538, UG3DA044823, U24DA048538, U24DA048538, U24DA048538, U24DA048538)
- License Information
-
More Information
Article History
Received: 6 February 2023
Accepted: 21 March 2024
First Online: 23 April 2024
Declarations
:
: Each of the seven individual studies within ROI conducted this study in accordance with relevant guidelines and regulations and obtained ethical approval from their local institutional ethics committees and all participants gave informed consent before participating. The University of Wisconsin-Madison Health Sciences IRB provided a waiver for parental consent for participants aged 15-17 from that study. Cross-study analyses presented here are based on deidentified data that has been harmonized from all ROI studies and this work has been approved by the University of Washington Human Subjects Division IRB committee J (Study00006739).
: Not applicable.
: The authors declare that they have no competing interests.
